From: Evaluation of recombinant porin (rOmp2a) protein as a potential antigen candidate for serodiagnosis of Human Brucellosis
S.No.
Group
Positive by iELISA
Negative by iELISA
1
I
14(93.3%)
1(6.66%)
2
II
23(82.1%), 25(96.1%)
5(17.8%), 1(3.8%)
3
III
1(3.8%), 3(9.37%)
25(96.1%), 29(90.6%)
4
IV
2(5.7%)
33(94.2%)
5
V
1(4.3%)
22(95.6%)